Quarterly report [Sections 13 or 15(d)]

Condensed Consolidated Balance Sheets

v3.26.3
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Sep. 30, 2026
Dec. 31, 2025
 [1]
Current Assets:    
Cash and cash equivalents $ 23,595 $ 23,415
Restricted cash 2,055 2,258
Accounts receivable (net of allowance for credit losses of $44 and $76, respectively) 64,325 55,069
Inventories 54,309 61,676
Transferable tax credits, net 15,829 7,500
Derivative instruments 5,332 525
Other current assets 4,261 5,474
Total current assets 169,706 155,917
Property and equipment, net 195,568 198,501
Other Assets:    
Right of use operating lease assets, net 20,209 16,931
Intangible assets, net 6,887 7,574
Other assets 10,080 9,863
Total other assets 37,176 34,368
Total Assets 402,450 388,786
Current Liabilities:    
Accounts payable 19,751 14,509
Accrued liabilities 18,048 16,691
Current portion – long-term debt 16,600
Current portion – operating leases 5,536 4,958
Derivative instruments 1,242 1,067
Other current liabilities 5,519 5,246
Total current liabilities 50,096 59,071
Long-term debt, net 54,468 63,027
Operating leases, net of current portion 15,606 13,012
Other liabilities 8,826 8,435
Total Liabilities 128,996 143,545
Commitments and Contingencies (Note 6)
Stockholders’ Equity:    
Preferred stock, $0.001 par value; 10,000 shares authorized; Series A: 1,684 shares authorized; no shares issued and outstanding as of September 30, 2026 and December 31, 2025; Series B: 1,581 shares authorized; 927 shares issued and outstanding as of September 30, 2026 and December 31, 2025; liquidation preference of $18,075 as of September 30, 2026 1 1
Common stock, value 78 77
Additional paid-in capital 1,051,959 1,051,795
Accumulated other comprehensive income 5,461 5,461
Accumulated deficit (784,045) (812,093)
Total Stockholders’ Equity 273,454 245,241
Total Liabilities and Stockholders’ Equity 402,450 388,786
Non-Voting Common Stock    
Stockholders’ Equity:    
Common stock, value
[1] Amounts derived from the audited consolidated financial statements for the year ended December 31, 2025.